Gland Pharma - GLAND, 543245 corporate action history

Gland Pharma Ltd.

NSE: GLAND | BSE: 543245

Strong Performer, Getting Expensive

Download real time

2543.70 115.40 (4.75%)

Near 52W High of ₹2573.50

1.0M

NSE+BSE Volume

NSE 29 Jul, 2026 3:58 PM (IST)

US FDA Approval

Gland Pharma gets US FDA approval for an anaesthesia reversal drug, with US sales of around $1.6 bn See details

Gland Pharma Bonus history

Gland Pharma has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Gland Pharma Split history

Gland Pharma has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Gland Pharma

Gland Pharma has declared 3 dividends since Aug. 16, 2024.

In the past 12 months, Gland Pharma has declared an equity dividend amounting to ₹18.00 per share.

At the current share price of ₹2543.7000, Gland Pharma's dividend yield is 0.71%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
11 Aug 2026	20.000	FINAL	11 Aug 2026	Equity Share
14 Aug 2025	18.000	FINAL	14 Aug 2025	Equity Share
16 Aug 2024	20.000	FINAL	16 Aug 2024	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Gland Pharma

The next board meeting for Gland Pharma is on 10 Aug 2026 for the purpose of Quarterly Results

Ex-Date	Purpose	Notes
10 Aug 2026	Quarterly Results	-
15 May 2026	Audited Results & Final Dividend	-
28 Jan 2026	Quarterly Results	-
03 Nov 2025	Quarterly Results	-
05 Aug 2025	Quarterly Results	-
20 May 2025	Audited Results & Final Dividend	-
03 Feb 2025	Quarterly Results	-
04 Nov 2024	Quarterly Results	-
06 Aug 2024	Quarterly Results	-
22 May 2024	Audited Results & Final Dividend	-

See all Board Meetings for Gland Pharma

Gland Pharma Rights history

Gland Pharma has not issued any rights since Jan 1, 2000.

See all Rights History for Gland Pharma

VOTE: Is Gland Pharma Ltd. worth buying?

215 Votes:

Buy 80.93%

Sell 9.3%

Hold 9.77%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >